450 related articles for article (PubMed ID: 24568869)
1. Trans-scleral local resection of toxic choroidal melanoma after proton beam radiotherapy.
Konstantinidis L; Groenewald C; Coupland SE; Damato B
Br J Ophthalmol; 2014 Jun; 98(6):775-9. PubMed ID: 24568869
[TBL] [Abstract][Full Text] [Related]
2. Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.
Riechardt AI; Pilger D; Cordini D; Seibel I; Gundlach E; Hager A; Joussen AM
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2263-2269. PubMed ID: 28721444
[TBL] [Abstract][Full Text] [Related]
3. Endoresection of choroidal melanoma.
Damato B; Groenewald C; McGalliard J; Wong D
Br J Ophthalmol; 1998 Mar; 82(3):213-8. PubMed ID: 9602614
[TBL] [Abstract][Full Text] [Related]
4. Choroidal melanoma: does endoresection prevent neovascular glaucoma in patient treated with proton beam irradiation?
Cassoux N; Cayette S; Plancher C; Lumbroso-Le Rouic L; Levy-Gabriel C; Asselain B; Sastre X; Couturier J; Arrufat S; Piperno-Neumann S; Dendale R; Lehoang P; Desjardins L
Retina; 2013; 33(7):1441-7. PubMed ID: 23514798
[TBL] [Abstract][Full Text] [Related]
5. Rhegmatogenous retinal detachment after transscleral local resection of choroidal melanoma.
Damato B; Groenewald CP; McGalliard JN; Wong D
Ophthalmology; 2002 Nov; 109(11):2137-43. PubMed ID: 12414429
[TBL] [Abstract][Full Text] [Related]
6. [Trans-scleral resection of the ciliary body and choroidal melanoma].
Romanowska-Dixon B; Starzycka M; Pogrzebielski A
Klin Oczna; 2000; 102(5):323-6. PubMed ID: 11286105
[TBL] [Abstract][Full Text] [Related]
7. Intracameral bevacizumab in the treatment of neovascular glaucoma and exudative retinal detachment after brachytherapy in choroidal melanoma.
Vásquez LM; Somani S; Altomare F; Simpson ER
Can J Ophthalmol; 2009 Feb; 44(1):106-7. PubMed ID: 19169330
[No Abstract] [Full Text] [Related]
8. Transpalpebral proton beam radiotherapy of choroidal melanoma.
Konstantinidis L; Roberts D; Errington RD; Kacperek A; Heimann H; Damato B
Br J Ophthalmol; 2015 Feb; 99(2):232-5. PubMed ID: 25138766
[TBL] [Abstract][Full Text] [Related]
9. Management of exudative retinal detachment in choroidal melanoma.
Gibran SK; Kapoor KG
Clin Exp Ophthalmol; 2009 Sep; 37(7):654-9. PubMed ID: 19788660
[TBL] [Abstract][Full Text] [Related]
10. Transscleral resection without hypotensive anaesthesia vs iodine-125 plaque brachytherapy in the treatment of choroidal melanoma.
Caminal JM; Padrón-Pérez N; Arias L; Masuet-Aumatell C; Gutiérrez C; Piulats JM; Pera J; Català J; Rubio MJ; Arruga J
Eye (Lond); 2016 Jun; 30(6):833-42. PubMed ID: 27034202
[TBL] [Abstract][Full Text] [Related]
11. Systemic bevacizumab (Avastin) for exudative retinal detachment secondary to choroidal melanoma.
Newman H; Finger PT; Chin KJ; Pavlick AC
Eur J Ophthalmol; 2011; 21(6):796-801. PubMed ID: 21445839
[TBL] [Abstract][Full Text] [Related]
12. [Surgical management of choroidal melanoma].
Romanowska-Dixon B
Klin Oczna; 2005; 107(10-12):635-41. PubMed ID: 16619808
[TBL] [Abstract][Full Text] [Related]
13. [Choroidal melanoma treated by protontherapy: anatomical and functional results at Strasbourg University Medical Center].
Saleh M; Zhang J; Benichou C; Hermsdorff C; Bourcier T; Sauer A; Speeg-Schatz C; Gaucher D
J Fr Ophtalmol; 2013 Sep; 36(7):583-8. PubMed ID: 23809200
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab for neovascular glaucoma in uveal melanoma treated by proton beam therapy.
Mahdjoubi A; Najean M; Lemaitre S; Dureau S; Dendale R; Levy C; Rouic LL; Desjardins L; Cassoux N
Graefes Arch Clin Exp Ophthalmol; 2018 Feb; 256(2):411-420. PubMed ID: 29116399
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcome of primary endoresection of choroidal melanoma.
Konstantinidis L; Groenewald C; Coupland SE; Damato B
Br J Ophthalmol; 2014 Jan; 98(1):82-5. PubMed ID: 24169650
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors of visual outcome after local resection of choroidal melanoma.
Damato BE; Paul J; Foulds WS
Br J Ophthalmol; 1993 Oct; 77(10):616-23. PubMed ID: 8218028
[TBL] [Abstract][Full Text] [Related]
17. Role of vitreoretinal surgery in maximizing treatment outcome following complications after proton therapy for uveal melanoma.
Tran BK; Schalenbourg A; Bovey E; Zografos L; Wolfensberger TJ
Retina; 2013 Oct; 33(9):1777-83. PubMed ID: 23792487
[TBL] [Abstract][Full Text] [Related]
18. [Trans-scleral resection of choroidal malignant melanoma].
Pecold K; Kociecki J
Klin Oczna; 2000; 102(5):327-30. PubMed ID: 11286106
[TBL] [Abstract][Full Text] [Related]
19. Proton beam radiotherapy of choroidal melanoma: the Liverpool-Clatterbridge experience.
Damato B; Kacperek A; Chopra M; Campbell IR; Errington RD
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1405-11. PubMed ID: 16029800
[TBL] [Abstract][Full Text] [Related]
20. Transscleral resection versus iodine brachytherapy for choroidal malignant melanomas 6 millimeters or more in thickness: a matched case-control study.
Kivelä T; Puusaari I; Damato B
Ophthalmology; 2003 Nov; 110(11):2235-44. PubMed ID: 14597535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
